Characterization of a pH-sensitive surfactant, dodecyl-2-(1'-imidazolyl) propionate (DIP), and preliminary studies in liposome mediated gene transfer

Biochimica et Biophysica Acta - Biomembranes

Volumn 1369, Issue 1, 1998, Pages 39-50

  Liang, Earvin ^a   Hughes, Jeffrey ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Endocytosis; Gene delivery; Liposome; pH sensitivity; Surfactant

Indexed keywords

LIPOSOME; PROPIONIC ACID DERIVATIVE; SURFACTANT;

ARTICLE; CELL PH; CLONING VECTOR; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

FLUORESCEINS; GENE TRANSFER TECHNIQUES; HUMANS; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; LIPOSOMES; SOLUBILITY; SURFACE-ACTIVE AGENTS; TUMOR CELLS, CULTURED;

EID: 0032472856     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(97)00172-7     Document Type: Article

References (33)

1. [1] H.E.J. Hofland, L. Shephard, S.M. Sullivan, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7305-7309.
2. [2] H. Gershon, R. Ghirlando, S.B. Gutman, A. Minsky, Biochemistry 32 (1993) 7143-7153.
3. [3] M. Lemaitre, B. Bayard, B. Lebleu, Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 648-652.
4. [4] J.F. Kukowsak-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Romalial, J.R.J. Baker, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4897-4902.
5. [5] P. Hug, R.G. Sleight, J. Biol. Chem. 269 (1994) 4050-4056.
6. [6] L. Carrasco, FEBS lett. 350 (1994) 151-154.
7. [7] C.J. Chu, J. Dijkstra, M.Z. Lai, K. Hong, F.C. Szoka, Pharm. Res. 7 (1990) 824-834.
8. [8] Y.G. Yu, D.S. King, Y.K. Shin, Science 266 (1994) 274-276.
9. [9] E. Fattal, S. Nir, R.A. Parente, F.C. Szoka, Biochemistry 33 (1994) 6721-6731.
10. [10] R.A. Parente, S. Nir, F.C. Szoka, Biochemistry 29 (1990) 8720-8728.
11. [11] S. Akhtar, R.L. Juliano, Trends Cell Biol. 2 (1992) 139-144.
12. [12] P.L. Felgner, T.R. Gadek, M. Homn, R. Roman, H.W. Chan, J.P. Wenz, G.M. Ringold, M. Danielsen, Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 7413-7417.
13. [13] J. Zabner, A.J. Fasbender, T. Moninger, K.A. Foellinger, M.J. Welsh, J. Biol. Chem. 270 (1995) 18977-19007.
14. [14] P. Pinnaduwage, L. Schmitt, L. Huang, Biochim. Biophys. Acta 985 (1989) 33-37.
15. [15] R.A. Firestone, J.M. Pisano, J. Med. Chem. 22 (1979) 1130-1133.
16. [16] C. de Duve, T. de Barsy, B. Poole, A. Trouet, P. Tulkens, F. Van Hoof, Biochem. Pharmacol. 23 (1974) 2495-2531.
17. [17] A. Trauet, D. Deprex-de Campaneere, C. de Duve, Nat. New Biol. 239 (1972) 110-112.
18. [18] J.A. Hughes, A.I. Aronsohn, A.V. Avrutskaya, R.L. Juliano, Pharm. Res. 13 (1996) 404-410.
19. [19] F. Szoka, D. Papahadjopoulos, Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 4194-4198.
20. [20] J.C.M. Stewart, Anal. Biochem. 104 (1980) 10-14.
21. [21] A. Martin, Physical Pharmacy, 4th ed., Lea and Febiger: Philadelphia, 1993.
22. [22] Y. Liu, S.L. Regen, J. Am. Chem. Soc. 115 (1993) 708-713.
23. [23] J. Ruiz, F.M. Goni, A. Alonso, Biochim. Biophys. Acta 937 (1988) 127-134.
24. [24] D. Lichtenberg, Y. Zilberman, P. Greenzaid, S. Zamir, Biochemistry 18 (1979) 3517-3525.
25. [25] M.L. Jackson, C.F. Schmidt, D. Lichtenberg, B.J. Litman, A.D. Albert, Biochemistry 21 (1982) 4576-4582.
26. [26] H. Ellens, J. Bentz, F.C. Szoka, Biochemistry 23 (1984) 1532-1538.
27. [27] S.P.C. Cole, Cancer Chemother. Pharmacol. 17 (1986) 259-263.
28. [28] A.R. Brasier, Biotechniques 7 (1989) 1116-1122.
29. [29] E. de Vendittis, G. Palumbo, G. Parlato, V. Bocchini, Anal. Biochem. 115 (1981) 278-286.
30. [30] D. Lichtenberg, Biochim. Biophys. Acta 821 (1985) 470-478.
31. [31] I. Solodin, C.S. Brown, M.S. Bruno, C. Chow, E. Jang, R.J. Debs, T.D. Health, Biochemistry 34 (1995) 13537-13544.
32. [32] R.L. Juliano, in: G.V.R. Born, P. Cuatrecasas, H. Herken (Eds.), Targeted Drug Delivery. Handbook in Experimental Pharmacology, Vol. 100, Springer-Verlag, Berlin, 1991.
33. [33] J. Lasch, Biochim. Biophys. Acta 1241 (1995) 269-292.